Home › Funds › PFIZER INC › ZNTL

PFIZER INC position in ZNTL

ZENTALIS PHARMACEUTICALS INC · Health Care

PFIZER INC reported holding 953,834 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 1.57% of its reported portfolio and ranking #12 among its reported holdings. PFIZER INC has disclosed ZNTL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)953.83K sh
Reported value held$2.58M
Portfolio Weight1.57%
First reportedQ4 2024
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How PFIZER INC's ZNTL position evolved

PFIZER INC first disclosed a stake in ZNTL in Q4 2024 at 953,834 shares (US$2.9M). The position peaked in Q2 2026 at 953,834 shares, worth US$3.9M. Across 8 filings, PFIZER INC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 953,834 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 953.83K $2.89M New
Q1 2025 953.83K $1.52M Hold
Q2 2025 953.83K $1.11M Hold
Q3 2025 953.83K $1.44M Hold
Q4 2025 953.83K $1.29M Hold
Q1 2026 953.83K $2.00M Hold
Q2 2026 953.83K $3.85M Hold
Q3 2026 953.83K $2.58M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZNTL and 13F data

ZNTL (ZENTALIS PHARMACEUTICALS INC) is a Health Care company. 29 other funds we track also report a position in ZNTL — the largest reported positions include 5AM Venture Management, LLC (US$19.1M), Opaleye Management Inc. (US$6.9M), Decheng Capital LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZNTL

All ZNTL fund holders →

FAQ

How long has PFIZER INC held ZNTL?

PFIZER INC has disclosed ZNTL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is PFIZER INC's current position in ZNTL?

As of Q3 2026, PFIZER INC holds 953.83K shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $2.58M, representing 1.57% of its reported portfolio and ranking #12.

Has PFIZER INC been buying or selling ZNTL?

In the latest 13F filing (Q3 2026), PFIZER INC held unchanged its position in ZNTL. The position peaked in Q2 2026 at 953.83K shares.

Which other funds hold ZNTL?

Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Decheng Capital LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.